This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Currently, Qulipta is not available as a genericmedicine. Aimovig was the first ever FDA-approved CGRP receptor antagonist in 2018. Qulipta ( atogepant ) is a brand-name prescription medication used to prevent migraine headaches (both chronic and episodic migraines ).
The strategy to build in cancer dates back to 2015, and has since gathered momentum with the purchase of the oncology businesses of Shire and Agios Pharma in 2018 and 2020, for $2.4 billion and $1.8 billion respectively, as well as smaller deals such as its takeover of Danish antibody specialist Symphogen.
It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s genericmedicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US.
Astellas has won a reprieve in its attempt to stop Pfizer’s genericmedicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks.
The first version of a list of critical medicines was published in 2023, with the aim to prevent disruption and help track EU manufacturing capacity and ensure the security of supply and availability of critical medicines at the EU level. This platform is expected to be operational by early 2025.
Generic Cialis became available in the United States after the exclusivity patent for Cialis , held by Eli Lilly, expired in 2018. As a genericmedicine, tadalafil offers the same benefits and uses as Cialis but typically at a lower price. It may be an appealing choice for those seeking treatment for ED and BPH.
“Now more than ever, it is our responsibility as a sector to ensure affordable access to healthcare and enable the future longevity of medicine development and supply.”. The genericsmedicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in. Delivery of essential medicines.
Novartis revealed today that it may consider divesting its genericmedicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines.
Koye sells genericmedicines, including COPD therapies such as Spirodin (doxofylline) and Spirodin-Ax (doxofylline and ambroxol), used to reduce open the airways and reduce coughing in patients with the respiratory condition.
Studies like this one from 2019 which assessed medications for blood pressure, diabetes, osteoporosis, and psychiatric conditionsshow that genericmedicines can deliver very similar outcomes to brand-name drugs. It also blocks 5HT3 serotonin receptors, which may help with nausea and also add benefits to mood.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content